Company
Therapeutic Focus
Pipeline
UNI-494
Renazorb
Investors
Contact
All SEC Filings
Investors
Investors
Overview
News
Events & Presentations
IR Calendar
Presentations
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Financial Results
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
Contacts
FAQ
Email Alerts
Filing Type:
View All
10-K
10-Q
3
4
424B4
8-A12B
8-K
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
03/13/23
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
03/09/23
4
Statement of changes in beneficial ownership of securities
1
03/09/23
4
Statement of changes in beneficial ownership of securities
1
03/09/23
4
Statement of changes in beneficial ownership of securities
1
03/09/23
4
Statement of changes in beneficial ownership of securities
1
03/08/23
3
Initial statement of beneficial ownership of securities
1
03/06/23
8-K
Current report filing
Documents
expand_more
EX-3.1
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-10.1
EX-10.2
EX-99.1
66
03/02/23
8-K
Current report filing
2
02/14/23
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/14/23
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
rss_feed
Filing RSS
1
2
3
4
5
6
7
8
9
10
arrow_forward
Email Alerts
Contacts
RSS News Feed